Buy Aurobindo Pharma Ltd

Buy Aurobindo Pharma Ltd

Aurobindo Pharma Ltd (ARBN):

Aurobindo Pharma Ltd has officially announced a consolidated sales of Rs. 6,063.40 Cr for the quarter finished on 31-03-2020, which is 4.55% up from its previous quarter sales of Rs. 5,799.44 Cr and 16.56% up from its previous year’s same quarter sales of Rs. 5,201.98 Cr. The firm has also announced its net profit after tax of Rs. 868.30 Cr in the most recent quarter.

Outlook:

Aurobindo Pharma Ltd is a buy call with a target of Rs. 870.

Disclaimer: The perspectives and investment tips are given in this section are the expert’s own and not that of the website or its management. We encourage clients to check with certified experts before taking any position in the stocks/shares mentioned.

Related posts

Buy L&T Finance, NIIT Tech, ICICI Bank & Jubilant Foods

jabili

Buy Coal India, Himatsingka Seide, Advanced Enzyme & Lupin

jabili

Sell Nifty 50, Coal India & Steel Authority of India Ltd

jabili